To improve hiring and user fee calculations, the US Food and Drug Administration is attempting to predict drug development activity for the entire pharmaceutical industry.
The models, which employ internal FDA data, as well as information from clinicaltrials
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?